- Home
- CYRX vs TBLA Comparison
CYRX vs TBLA Comparison
Compare CYRX & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | TBLA |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.3M | 921.2M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CYRX | TBLA |
|---|---|---|
| Price | $18.62 | $3.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $19.78 | $5.70 |
| AVG Volume (30 Days) | 651.0K | ★ 1.6M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 156.22 | ★ 1400.00 |
| EPS | N/A | ★ 220.00 |
| Revenue | $176,177,000.00 | ★ $1,912,040,000.00 |
| Revenue This Year | $10.95 | $1.65 |
| Revenue Next Year | $10.11 | $5.39 |
| P/E Ratio | ★ N/A | $0.02 |
| Revenue Growth | N/A | ★ 8.26 |
| 52 Week Low | $7.61 | $2.84 |
| 52 Week High | $18.73 | $5.71 |
Technical Indicators
Market Signals| Indicator | CYRX | TBLA |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 47.26 |
| Support Level | $14.55 | $3.18 |
| Resistance Level | N/A | $3.52 |
| Average True Range (ATR) | 0.73 | 0.10 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 93.82 | 51.16 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
About TBLA Taboola.com Ltd.
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.